Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

secretome

Phase 2Cell therapy

secretome is one of 105 biologic programs targeting Acne Vulgaris. It is currently in Phase 2.

4

Indications

10

Total Trials

6

Active Trials

104

Competitors

Pipeline

Status by Indication[3][1]

Indication

Acne VulgarisNot yet recruiting

EpilepsyNot yet recruiting

CirrhosisNot yet recruiting

Androgenetic AlopeciaRecruiting

Acne VulgarisPhase 2

Not yet recruiting

EpilepsyPhase 1

Not yet recruiting

CirrhosisPhase 1

Not yet recruiting

Androgenetic AlopeciaPhase 2

Recruiting

Competition

Competitive Landscape

84 competitors in Epilepsy

#DrugCompanyPhaseTrials

Keppra

Vimpat

Tegretol

Trileptal

Fycompa

CCatalyst Biosciences

Diamox

Briviact

Dilantin

VViatris Specialty LLC

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Zoloft

VViatris Specialty LLC

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 1/2Recruiting

Androgenetic Alopecia

NCT07429253

Q4 2026

Phase 1Not yet recruiting

Epilepsy

NCT06638970

Phase 1Not yet recruiting

Cirrhosis

NCT06629909

Clinical

Trials by Indication[1]

Epilepsy1 trial

Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial

Not yet recruiting·BBaermed·Phase 1·NCT06638970·54 enrolled

Androgenetic Alopecia1 trial

Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

Recruiting·PPT. Prodia Stem Cell Indonesia·Phase 1/2·NCT07429253·40 enrolled

Cirrhosis1 trial

Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

Not yet recruiting·BBaermed·Phase 1·NCT06629909·54 enrolled

Mesenchymal Stem Cell1 trial

The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

Completed·UUniversitas Sebelas Maret·Phase 1/2·NCT05921058·15 enrolled

Cognitive impairment1 trial

Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)

Not yet recruiting·BBaermed·Phase 1·NCT06632470·54 enrolled

5 more indications

TIA1 trial

Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)

Completed·YYohanes Firmansyah, dr, MH, MM·Phase 1·NCT05777213·27 enrolled

Stem Cell1 trial

Skin Rejuvenation Using Stem Cell Secretome

Completed·CCOR clinic of Regenerative Medicine·Phase 1·NCT06217627·49 enrolled

Acne Vulgaris1 trial

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Not yet recruiting·UUniversitas Padjadjaran·Phase 2·NCT06925386·64 enrolled

Carpal Tunnel Syndrome (CTS)1 trial

Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation Using the Boston Carpal Tunnel Questionnaire and Electromyography

Recruiting·PPT. Prodia Stem Cell Indonesia·Phase 1·NCT07723313·30 enrolled

ACL Injury1 trial

Comparison of Six-Month Functional Outcomes Following Anterior Cruciate Ligament (ACL) Reconstruction Using Peroneus Longus Tendon Grafts With Adjunctive Secretome Injection Versus Without Secretome Injection

Completed·PPT. Prodia Stem Cell Indonesia·Preclinical·NCT07723625·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for secretome. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — secretome compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for secretome. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Baermed company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Cell therapy[2]
Highest Phase: Phase 2[1]
Company: BBaermed

Related News